Join
Live feed
·
INSIDERFilingvia Quantisnow
Royalty Pharma plc logo

EVP, Research & Investments Urist Marshall sold $502,067 worth of Class A Ordinary Shares (9,098 units at $55.18) as part of a pre-agreed trading plan, decreasing direct ownership by 50% to 9,099 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RPRX· Royalty Pharma plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RPRX (Royalty Pharma plc) and more on Quantisnow.

EVP, Research & Investments Urist Marshall sold $502,067 worth of Class A Ordinary Shares (9,098 units at $55.18) as part of a pre-agreed trading plan, decreasing direct ownership by 50% to 9,099 units (SEC Form 4) | Quantisnow